466 related articles for article (PubMed ID: 22050009)
1. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
[TBL] [Abstract][Full Text] [Related]
2. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Eur J Clin Invest; 2012 Mar; 42(3):266-74. PubMed ID: 21834799
[TBL] [Abstract][Full Text] [Related]
3. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV;
J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302
[TBL] [Abstract][Full Text] [Related]
4. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.
Hulot JS; Collet JP; Silvain J; Pena A; Bellemain-Appaix A; Barthélémy O; Cayla G; Beygui F; Montalescot G
J Am Coll Cardiol; 2010 Jul; 56(2):134-43. PubMed ID: 20620727
[TBL] [Abstract][Full Text] [Related]
6. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.
Charlot M; Ahlehoff O; Norgaard ML; Jørgensen CH; Sørensen R; Abildstrøm SZ; Hansen PR; Madsen JK; Køber L; Torp-Pedersen C; Gislason G
Ann Intern Med; 2010 Sep; 153(6):378-86. PubMed ID: 20855802
[TBL] [Abstract][Full Text] [Related]
7. Major adverse cardiac events among postpercutaneous coronary intervention patients on clopidogrel and proton pump inhibitors.
Ching GG; Li D; Baker WL; Hohl PK; Mather JF; McKay RG; Lundbye JB
Conn Med; 2012 Apr; 76(4):205-11. PubMed ID: 22611719
[TBL] [Abstract][Full Text] [Related]
8. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
9. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
[TBL] [Abstract][Full Text] [Related]
10. Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Baron JA; Sørensen HT
Br J Clin Pharmacol; 2012 Jul; 74(1):161-70. PubMed ID: 22243420
[TBL] [Abstract][Full Text] [Related]
11. Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.
Zuern CS; Geisler T; Lutilsky N; Winter S; Schwab M; Gawaz M
Thromb Res; 2010 Feb; 125(2):e51-4. PubMed ID: 19781742
[TBL] [Abstract][Full Text] [Related]
12. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
Goodman SG; Clare R; Pieper KS; Nicolau JC; Storey RF; Cantor WJ; Mahaffey KW; Angiolillo DJ; Husted S; Cannon CP; James SK; Kilhamn J; Steg PG; Harrington RA; Wallentin L;
Circulation; 2012 Feb; 125(8):978-86. PubMed ID: 22261200
[TBL] [Abstract][Full Text] [Related]
13. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
[TBL] [Abstract][Full Text] [Related]
14. Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.
Gaglia MA; Torguson R; Hanna N; Gonzalez MA; Collins SD; Syed AI; Ben-Dor I; Maluenda G; Delhaye C; Wakabayashi K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2010 Mar; 105(6):833-8. PubMed ID: 20211327
[TBL] [Abstract][Full Text] [Related]
15. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
[TBL] [Abstract][Full Text] [Related]
16. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.
Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S
Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557
[TBL] [Abstract][Full Text] [Related]
17. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
Sarafoff N; Sibbing D; Sonntag U; Ellert J; Schulz S; Byrne RA; Mehilli J; Schömig A; Kastrati A
Thromb Haemost; 2010 Sep; 104(3):626-32. PubMed ID: 20664905
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
Laine L; Hennekens C
Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal antiinflammatory drug use and cardiovascular risks after coronary stent implantation.
Schmidt M; Pedersen L; Maeng M; Lassen JF; Lash TL; Nielsen TT; Sørensen HT
Pharmacotherapy; 2011 May; 31(5):458-68. PubMed ID: 21923427
[TBL] [Abstract][Full Text] [Related]
20. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.
Huang CC; Chen YC; Leu HB; Chen TJ; Lin SJ; Chan WL; Chen JW
Am J Cardiol; 2010 Jun; 105(12):1705-9. PubMed ID: 20538118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
